Position
Fidelity in Supernus Pharmaceuticals, Inc.
Back to the book · All holders of SUPN
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$1.08M$51.69 → $46.51
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 124.3K | $6.18M | — | — | — | 0.0% |
| Q1 2026 | 209.4K | $10.8M | $51.69 | $247.4K | $4.4M | 0.0% |
| Q2 2026 | 309.1K | $14.4M | $46.51 | −$1.08M | $4.64M | 0.0% |